Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 103

1.

Analysis of luteinizing hormone (LH): Validation of a commercial ELISA kit for LH analysis and quantification in doping control samples.

Mäkelä R, Leinonen A, Suominen T.

Drug Test Anal. 2019 Oct 26. doi: 10.1002/dta.2716. [Epub ahead of print]

PMID:
31655497
2.

Intensity and temporal patterns of physical activity and cardiovascular disease risk in midlife.

Niemelä M, Kangas M, Farrahi V, Kiviniemi A, Leinonen AM, Ahola R, Puukka K, Auvinen J, Korpelainen R, Jämsä T.

Prev Med. 2019 Jul;124:33-41. doi: 10.1016/j.ypmed.2019.04.023. Epub 2019 Apr 30.

3.

Dose-response relation of self-reported and accelerometer-measured physical activity to perceived health in middle age-the Northern Finland Birth Cohort 1966 Study.

Niemelä MS, Kangas M, Ahola RJ, Auvinen JP, Leinonen AM, Tammelin TH, Vaaramo ES, Keinänen-Kiukaanniemi SM, Korpelainen RI, Jämsä TJ.

BMC Public Health. 2019 Jan 7;19(1):21. doi: 10.1186/s12889-018-6359-8.

4.

Feasibility of Gamified Mobile Service Aimed at Physical Activation in Young Men: Population-Based Randomized Controlled Study (MOPO).

Leinonen AM, Pyky R, Ahola R, Kangas M, Siirtola P, Luoto T, Enwald H, Ikäheimo TM, Röning J, Keinänen-Kiukaanniemi S, Mäntysaari M, Korpelainen R, Jämsä T.

JMIR Mhealth Uhealth. 2017 Oct 10;5(10):e146. doi: 10.2196/mhealth.6675.

5.

Measuring Physical Activity in Free-Living Conditions-Comparison of Three Accelerometry-Based Methods.

Leinonen AM, Ahola R, Kulmala J, Hakonen H, Vähä-Ypyä H, Herzig KH, Auvinen J, Keinänen-Kiukaanniemi S, Sievänen H, Tammelin TH, Korpelainen R, Jämsä T.

Front Physiol. 2017 Jan 10;7:681. doi: 10.3389/fphys.2016.00681. eCollection 2016.

6.

Corrigendum to "Analysis of anabolic steroids in urine by gas chromatography-microchip atmospheric pressure photoionization-mass spectrometry with chlorobenzene as dopant" [J. Chromatogr. A 1312 (2013) 111-117].

Hintikka L, Haapala M, Kuuranne T, Leinonen A, Kostiainen R.

J Chromatogr A. 2016 May 27;1448:128. doi: 10.1016/j.chroma.2016.04.059. Epub 2016 Apr 28. No abstract available.

PMID:
27133863
7.

What Data to Use for Forest Conservation Planning? A Comparison of Coarse Open and Detailed Proprietary Forest Inventory Data in Finland.

Lehtomäki J, Tuominen S, Toivonen T, Leinonen A.

PLoS One. 2015 Aug 28;10(8):e0135926. doi: 10.1371/journal.pone.0135926. eCollection 2015.

8.

Systematic Review: Representativeness of Participants in RCTs of Acetylcholinesterase Inhibitors.

Leinonen A, Koponen M, Hartikainen S.

PLoS One. 2015 May 1;10(5):e0124500. doi: 10.1371/journal.pone.0124500. eCollection 2015. Review.

9.

Targeting misuse of 2-amino-N-ethyl-1-phenylbutane in urine samples: in vitro-in vivo correlation of metabolic profiles and development of LC-TOF-MS method.

Kobayashi M, Pelander A, Ketola RA, Leinonen A, Kuuranne T.

Drug Test Anal. 2015 Feb;7(2):89-94. doi: 10.1002/dta.1642. Epub 2014 Mar 28.

PMID:
24687931
10.

Analysis of anabolic steroids in urine by gas chromatography-microchip atmospheric pressure photoionization-mass spectrometry with chlorobenzene as dopant.

Hintikka L, Haapala M, Kuuranne T, Leinonen A, Kostiainen R.

J Chromatogr A. 2013 Oct 18;1312:111-7. doi: 10.1016/j.chroma.2013.08.098. Epub 2013 Sep 5.

PMID:
24041507
11.

Analysis of human chorionic gonadotropin (hCG): application of routine immunological methods for initial testing and confirmation analysis in doping control.

Kuuranne T, Ahola L, Pussinen C, Leinonen A.

Drug Test Anal. 2013 Aug;5(8):614-8. doi: 10.1002/dta.1449. Epub 2013 Jan 10.

PMID:
23303576
12.

Transformation by stealth: the retargeting of home care services in Finland.

Kröger T, Leinonen A.

Health Soc Care Community. 2012 May;20(3):319-27. doi: 10.1111/j.1365-2524.2011.01047.x. Epub 2011 Dec 9.

PMID:
22151838
13.

Masters of their own time? Working carers' visions of retirement.

Leinonen A.

Eur J Ageing. 2011 Oct 6;8(4):243-253. doi: 10.1007/s10433-011-0200-x. eCollection 2011 Dec.

14.

Specific screening method for dextran and hydroxyethyl starch in human urine by size exclusion chromatography-in-source collision-induced dissociation-time-of-flight mass spectrometry.

Kolmonen M, Leinonen A, Kuuranne T, Pelander A, Deventer K, Ojanperä I.

Anal Bioanal Chem. 2011 Aug;401(2):563-71. doi: 10.1007/s00216-011-4838-1. Epub 2011 Mar 17.

PMID:
21416163
15.

Characterization of microbial contaminants in urine.

Ojanperä S, Leinonen A, Apajalahti J, Lauraeus M, Alaja S, Moisander T, Kettunen A.

Drug Test Anal. 2010 Nov-Dec;2(11-12):576-81. doi: 10.1002/dta.202. Epub 2010 Nov 11.

PMID:
21204289
16.

Feasibility of gas chromatography-microchip atmospheric pressure photoionization-mass spectrometry in analysis of anabolic steroids.

Hintikka L, Haapala M, Franssila S, Kuuranne T, Leinonen A, Kostiainen R.

J Chromatogr A. 2010 Dec 24;1217(52):8290-7. doi: 10.1016/j.chroma.2010.10.074. Epub 2010 Oct 23.

PMID:
21081231
17.

Hydrophilic interaction liquid chromatography and accurate mass measurement for quantification and confirmation of morphine, codeine and their glucuronide conjugates in human urine.

Kolmonen M, Leinonen A, Kuuranne T, Pelander A, Ojanperä I.

J Chromatogr B Analyt Technol Biomed Life Sci. 2010 Nov 1;878(29):2959-66. doi: 10.1016/j.jchromb.2010.08.047. Epub 2010 Sep 9.

PMID:
20880763
18.

Identification of free and conjugated metabolites of mesocarb in human urine by LC-MS/MS.

Gómez C, Segura J, Monfort N, Suominen T, Leinonen A, Vahermo M, Yli-Kauhaluoma J, Ventura R.

Anal Bioanal Chem. 2010 Aug;397(7):2903-16. doi: 10.1007/s00216-010-3756-y. Epub 2010 May 23.

PMID:
20496057
19.

Generic sample preparation and dual polarity liquid chromatography-time-of-flight mass spectrometry for high-throughput screening in doping analysis.

Kolmonen M, Leinonen A, Kuuranne T, Pelander A, Ojanperä I.

Drug Test Anal. 2009 Jun;1(6):250-66. doi: 10.1002/dta.50.

PMID:
20355204
20.

UDP-glucuronosyltransferases in conjugation of 5alpha- and 5beta-androstane steroids.

Sten T, Kurkela M, Kuuranne T, Leinonen A, Finel M.

Drug Metab Dispos. 2009 Nov;37(11):2221-7. doi: 10.1124/dmd.109.029231. Epub 2009 Aug 6.

PMID:
19661211
21.

Neurocognitive processing of auditorily and visually presented inflected words and pseudowords: evidence from a morphologically rich language.

Leinonen A, Grönholm-Nyman P, Järvenpää M, Söderholm C, Lappi O, Laine M, Krause CM.

Brain Res. 2009 Jun 12;1275:54-66. doi: 10.1016/j.brainres.2009.03.057. Epub 2009 Apr 9.

PMID:
19362541
22.

Synthesis and characterization of hydroxylated mesocarb metabolites for doping control.

Vahermo M, Suominen T, Leinonen A, Yli-Kauhaluoma J.

Arch Pharm (Weinheim). 2009 Apr;342(4):201-9. doi: 10.1002/ardp.200800144.

PMID:
19340833
23.

UDP-glucuronosyltransferases (UGTs) 2B7 and UGT2B17 display converse specificity in testosterone and epitestosterone glucuronidation, whereas UGT2A1 conjugates both androgens similarly.

Sten T, Bichlmaier I, Kuuranne T, Leinonen A, Yli-Kauhaluoma J, Finel M.

Drug Metab Dispos. 2009 Feb;37(2):417-23. doi: 10.1124/dmd.108.024844. Epub 2008 Nov 20.

PMID:
19022937
24.

Screening of in vitro synthesised metabolites of 4,9,11-trien-3-one steroids by liquid chromatography mass spectrometry.

Kuuranne T, Pystynen KH, Thevis M, Leinonen A, Schänzer W, Kostiainen R.

Eur J Mass Spectrom (Chichester). 2008;14(3):181-9. doi: 10.1255/ejms.923.

PMID:
18708698
25.

Liquid chromatographic-mass spectrometric analysis of glucuronide-conjugated anabolic steroid metabolites: method validation and interlaboratory comparison.

Hintikka L, Kuuranne T, Leinonen A, Thevis M, Schänzer W, Halket J, Cowan D, Grosse J, Hemmersbach P, Nielen MW, Kostiainen R.

J Mass Spectrom. 2008 Jul;43(7):965-73. doi: 10.1002/jms.1434.

PMID:
18563858
26.

Event-related potential (ERP) responses to violations of inflectional and derivational rules of Finnish.

Leinonen A, Brattico P, Järvenpää M, Krause CM.

Brain Res. 2008 Jul 7;1218:181-93. doi: 10.1016/j.brainres.2008.04.049. Epub 2008 Apr 27.

PMID:
18514637
27.

Insulins in equine urine: qualitative analysis by immunoaffinity purification and liquid chromatography/tandem mass spectrometry for doping control purposes in horse-racing.

Kuuranne T, Thomas A, Leinonen A, Delahaut P, Bosseloir A, Schänzer W, Thevis M.

Rapid Commun Mass Spectrom. 2008;22(3):355-62. doi: 10.1002/rcm.3360.

PMID:
18181226
28.

Aryl-propionamide-derived selective androgen receptor modulators: liquid chromatography-tandem mass spectrometry characterization of the in vitro synthesized metabolites for doping control purposes.

Kuuranne T, Leinonen A, Schänzer W, Kamber M, Kostiainen R, Thevis M.

Drug Metab Dispos. 2008 Mar;36(3):571-81. Epub 2007 Dec 17.

PMID:
18086831
29.

A general screening method for doping agents in human urine by solid phase extraction and liquid chromatography/time-of-flight mass spectrometry.

Kolmonen M, Leinonen A, Pelander A, Ojanperä I.

Anal Chim Acta. 2007 Feb 28;585(1):94-102. Epub 2006 Dec 23.

PMID:
17386652
30.

Electrophysiological correlates of memory processing in early Finnish-Swedish bilinguals.

Leinonen A, Laine M, Laine M, Krause CM.

Neurosci Lett. 2007 Apr 6;416(1):22-7. Epub 2007 Feb 24.

PMID:
17353093
31.

Modality matters: the effects of stimulus modality on the 4- to 30-Hz brain electric oscillations during a lexical decision task.

Krause CM, Grönholm P, Leinonen A, Laine M, Säkkinen AL, Söderholm C.

Brain Res. 2006 Sep 19;1110(1):182-92. Epub 2006 Aug 9.

PMID:
16901470
32.

Human and bovine milk oligosaccharides inhibit Neisseria meningitidis pili attachment in vitro.

Hakkarainen J, Toivanen M, Leinonen A, Frängsmyr L, Strömberg N, Lapinjoki S, Nassif X, Tikkanen-Kaukanen C.

J Nutr. 2005 Oct;135(10):2445-8.

PMID:
16177210
33.

[Doping and sports - what is the problem?].

Leinonen A, Kimmo K.

Duodecim. 2005;121(9):933-5. Finnish. No abstract available.

PMID:
15991736
34.

Functional analysis of immune response genes in Drosophila identifies JNK pathway as a regulator of antimicrobial peptide gene expression in S2 cells.

Kallio J, Leinonen A, Ulvila J, Valanne S, Ezekowitz RA, Rämet M.

Microbes Infect. 2005 May;7(5-6):811-9. Epub 2005 Apr 18.

PMID:
15890554
35.

Diurnal blood glucose profiles in women with gestational diabetes with or without hypertension.

Leinonen A, Hiilesmaa V, Andersen H, Teramo K, Kaaja R.

Diabet Med. 2004 Nov;21(11):1181-4.

PMID:
15498083
36.

Effect of changes in body posture on vasoactive hormones in pre-eclamptic women.

Kaaja RJ, Leinonen A, Moore P, Yandle T, Frampton CM, Nicholls MG.

J Hum Hypertens. 2004 Nov;18(11):789-94.

PMID:
15175632
37.
38.

[Can doping improve the performance of Santa's reindeer?].

Leinonen A, Kuoppasalmi K.

Duodecim. 2003;119(23):2331-5. Finnish. No abstract available.

PMID:
14768262
39.

Data modeling and data communication in GenomEUtwin.

Litton JE, Muilu J, Björklund A, Leinonen A, Pedersen NL.

Twin Res. 2003 Oct;6(5):383-90.

PMID:
14624722
40.

Feasibility of a liquid-phase microextraction sample clean-up and liquid chromatographic/mass spectrometric screening method for selected anabolic steroid glucuronides in biological samples.

Kuuranne T, Kotiaho T, Pedersen-Bjergaard S, Einar Rasmussen K, Leinonen A, Westwood S, Kostiainen R.

J Mass Spectrom. 2003 Jan;38(1):16-26.

PMID:
12526002
42.
43.

Autosomal dominant Alport syndrome caused by a COL4A3 splice site mutation.

van der Loop FT, Heidet L, Timmer ED, van den Bosch BJ, Leinonen A, Antignac C, Jefferson JA, Maxwell AP, Monnens LA, Schröder CH, Smeets HJ.

Kidney Int. 2000 Nov;58(5):1870-5.

44.

Electrospray and atmospheric pressure chemical ionization tandem mass spectrometric behavior of eight anabolic steroid glucuronides.

Kuuranne T, Vahermo M, Leinonen A, Kostianen R.

J Am Soc Mass Spectrom. 2000 Aug;11(8):722-30.

45.

The goodpasture autoantigen. Identification of multiple cryptic epitopes on the NC1 domain of the alpha3(IV) collagen chain.

Borza DB, Netzer KO, Leinonen A, Todd P, Cervera J, Saus J, Hudson BG.

J Biol Chem. 2000 Feb 25;275(8):6030-7.

46.
47.

The goodpasture autoantigen. Mapping the major conformational epitope(s) of alpha3(IV) collagen to residues 17-31 and 127-141 of the NC1 domain.

Netzer KO, Leinonen A, Boutaud A, Borza DB, Todd P, Gunwar S, Langeveld JP, Hudson BG.

J Biol Chem. 1999 Apr 16;274(16):11267-74.

48.
49.

High mutation detection rate in the COL4A5 collagen gene in suspected Alport syndrome using PCR and direct DNA sequencing.

Martin P, Heiskari N, Zhou J, Leinonen A, Tumelius T, Hertz JM, Barker D, Gregory M, Atkin C, Styrkarsdottir U, Neumann H, Springate J, Shows T, Pettersson E, Tryggvason K.

J Am Soc Nephrol. 1998 Dec;9(12):2291-301.

50.

Electrophysiological evidence for cross-modal plasticity in humans with early- and late-onset blindness.

Kujala T, Alho K, Huotilainen M, Ilmoniemi RJ, Lehtokoski A, Leinonen A, Rinne T, Salonen O, Sinkkonen J, Standertskjöld-Nordenstam CG, Näätänen R.

Psychophysiology. 1997 Mar;34(2):213-6.

PMID:
9090272

Supplemental Content

Loading ...
Support Center